Chronic methamphetamine regulates the expression of MicroRNAs and putative target genes in the nucleus accumbens of mice

Journal of Neuroscience Research

Volumn 93, Issue 10, 2015, Pages 1600-1610

  Zhu, Li ^a,b   Zhu, Jie ^a,b   Liu, Yufeng ^c   Chen, Yanjiong ^a   Li, Yanlin ^a,b   Chen, Sisi ^c   Li, Tao ^a,b   Dang, Yonghui ^a,b   Chen, Teng ^a,b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c BGI SHENZHEN   (China)

Author keywords

Methamphetamine; MicroRNA; RNA Seq; RRIDs; Target genes

Indexed keywords

MESSENGER RNA; METHAMPHETAMINE; MICRORNA; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; CENTRAL STIMULANT AGENT; CYTOSKELETON PROTEIN; NERVE PROTEIN; TRANSCRIPTOME;

ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL METABOLISM; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RNA SEQUENCE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GENOME; METABOLISM; NONPARAMETRIC TEST; SIGNAL TRANSDUCTION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; GENOME; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICRORNAS; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TRANSCRIPTOME;

EID: 84939449473     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23605     Document Type: Article

References (51)

1. Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R. 2014. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology 39:1066-1080.
2. Audic S, Claverie JM. 1997. The significance of digital gene expression profiles. Genome Res 7:986-995.
3. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Baskerville S, Bartel DP. 2005. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241-247.
5. Beique JC, Na Y, Kuhl D, Worley PF, Huganir RL. 2011. Arc-dependent synapse-specific homeostatic plasticity. Proc Natl Acad Sci U S A 108:816-821.
6. Bredy TW, Lin Q, Wei W, Baker-Andresen D, Mattick JS. 2011. MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem 96:89-94.
7. Bu Q, Lv L, Yan G, Deng P, Wang Y, Zhou J, Yang Y, Li Y, Cen X. 2013. NMR-based metabonomic in hippocampus, nucleus accumbens, and prefrontal cortex of methamphetamine-sensitized rats. Neurotoxicology 36:17-23.
8. Chandrasekar V, Dreyer J. 2009. microRNAs miR-124, let-7d, and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 42:350-362.
9. Chandraskear V, Dreyer J. 2011. Regulation of miR-124, let-7d, and miR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacol 36:1149-1164.
10. Chang L, Alicata D, Ernst T, Volkow N. 2007. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1):16-32.
11. Eipper-Mains JE, Kiraly DD, Palakodeti D, Mains RE, Eipper BA, Graveley BR. 2011. microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA 17:1529-1543.
12. Eipper-Mains JE, Eipper BA, Mains RE. 2012. Global approaches to the role of miRNAs in drug-induced changes in gene expression. Front Genet 3:109.
13. Farrell M, Marsden J, Ali R, Ling W. 2002. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 97:771-772.
14. Goswami S, Tarapore RS, Poenitzsch Strong AM, TeSlaa JJ, Grinblat Y, Setaluri V, Spiegelman VS. 2014. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant binding protein (CRD-BP). J Biol Chem 290:384-395.
15. Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD, Kenny PJ. 2010. Striatal microRNA controls cocaine intake through CREB signalling. Nature 466:197-202.
16. Hozumi H, Asanuma M, Miyazaki I, Fukuoka S, Kikkawa Y, Kimoto N, Kitamura Y, Sendo T, Kita T, Gomita Y. 2008. Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity. Toxicol Lett 177:123-129.
17. Huang J, Ju Z, Li Q, Hou Q, Wang C, Li J, Li R, Wang L, Sun T, Hang S, Gao Y, Hou M, Zhong J. 2011. Solexa sequencing of novel and differentially expressed microRNAs in testicular and ovarian tissues in Holstein cattle. Int J Biol Sci 7:1016-1026.
18. Huang WH, Li MD. 2009. Nicotine modulates expression of miR-140*, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). Int J Neuropsychopharmacol 12:537-546.
19. Im HI, Hollander JA, Bali P, Kenny PJ. 2010. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 13:1120-1127.
20. In SW, Son EW, Rhee DK, Pyo S. 2005. Methamphetamine administration produces immunomodulation in mice. J Toxicol Environ Health A 68:2133-2145.
21. Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126-139.
22. Kodama M, Akiyama K, Ujike H, Shimizu Y, Tanaka Y, Kuroda S. 1998. A robust increase in expression of arc gene, an effector immediate early gene, in the rat brain after acute and chronic methamphetamine administration. Brain Res 796:273-283.
23. Korb E, Wilkinson CL, Delgado RN, Lovero KL, Finkbeiner S. 2013. Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity. Nat Neurosci 16:874-883.
24. Kousik SM, Carvey PM, Napier TC. 2014. Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. Eur J Neurosci 40:2707-2714.
25. Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D. 2002. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci 22:8951-8960.
26. Li MD, van der Vaart AD. 2011. MicroRNAs in addiction: adaptation's middlemen? Mol Psychiatry 16:1159-1168.
27. Lippi G, Steinert JR, Marczylo EL, D'Oro S, Fiore R, Forsythe ID, Schratt G, Zoli M, Nicotera P, Young KW. 2011. Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J Cell Biol 194:889-904.
28. Loftis JM, Choi D, Hoffman W, Huckans MS. 2011. Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res 20:59-68.
29. McKetin R, Lubman DI, Najman JM, Dawe S, Butterworth P, Baker AL. 2014. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction 109:798-806.
30. Metzker ML. 2010. Sequencing technologies-the next generation. Nat Rev Genet 11:31-46.
31. Nakajima A, Yamada K, Nagai T, Uchiyama T, Miyamoto Y, Mamiya T, He J, Nitta A, Mizuno M, Tran MH, Seto A, Yoshimura M, Kitaichi K, Hasegawa T, Saito K, Yamada Y, Seishima M, Sekikawa K, Kim HC, Nabeshima T. 2004. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J Neurosci 24:2212-2225.
32. Numachi Y, Ohara A, Yamashita M, Fukushima S, Kobayashi H, Hata H, Watanabe H, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora L. 2007. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol 572:120-128.
33. Parkhomchuk D, Borodina T, Amstislavskiy V, Banaru M, Hallen L, Krobitsch S, Lehrach H, Soldatov A. 2009. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res 37:e123.
34. Pasquali L, Lazzeri G, Isidoro C, Ruggieri S, Paparelli A, Fornai F. 2008. Role of autophagy during methamphetamine neurotoxicity. Ann N Y Acad Sci 1139:191-196.
35. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
36. Peebles CL, Yoo J, Thwin MT, Palop JJ, Noebels JL, Finkbeiner S. 2010. Arc regulates spine morphology and maintains network stability in vivo. Proc Natl Acad Sci U S A 107:18173-18178.
37. Rawson RA, Condon TP. 2007. Why do we need an addiction supplement focused on methamphetamine? Addiction 102(Suppl 1):1-4.
38. Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, Cui Z, Zhang J, Yi K, Xu W, Chen C, Wang F, Guo X, Lu J, Yang J, Wei M, Tian Z, Guan Y, Tang L, Xu C, Wang L, Tian W, Wang J, Yang H, Sun Y. 2012. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs, and aberrant alternative splicings. Cell Res 22:806-821.
39. Robison AJ, Nestler EJ. 2011. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623-637.
40. T method. Nat Protoc 3:1101-1108.
41. Schratt G. 2009. microRNAs at the synapse. Nat Rev Neurosci 10:842-849.
42. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, Khudayberdiev S, Leuschner PF, Busch CJL, Kane C, Hubel K, Dekker F, Hedberg C, Rengarajan B, Drepper C, Waldmann H, Kauppinen S, Greenberg ME, Draguhn A, Rehmsmeier M, Martinez J, Schratt GM. 2009. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 11:705-716.
43. Siomi H, Siomi MC. 2009. On the road to reading the RNA-interference code. Nature 457:396-404.
44. Wu QF, Zhang L, Law PY, Wei LN, Loh HH. 2009. Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol Pharmacol 75:744-750.
45. Wu QF, Hwang CK, Zheng H, Wagley Y, Lin HY, Kim DK, Law PY, Loh HH, Wei LN. 2013. MicroRNA 339 downregulates μ-opioid receptor at the posttranscriptional level in response to opioid treatment. FASEB J 27:522-535.
46. Xu B, Hsu PK, Karayiorgou M, Gogos JA. 2012. MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis 46:291-301.
47. Yamagata K, Suzuki K, Sugiura H, Kawashima N, Okuyama S. 2000. Activation of an effector immediate-early gene arc by methamphetamine. Ann N Y Acad Sci 914:22-32.
48. Yang MH, Kim S, Jung MS, Shim JH, Ryu NK, Yook YJ, Jang CG, Bahk YY, Kim KW, Park JH. 2008. Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system. Addict Biol 13:287-294.
49. Zhao N, Chen Y, Zhu J, Wang L, Cao G, Dang Y, Yan C, Wang J, Chen T. 2014. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of Erk in the nucleus accumbens and caudate putamen in mice. Neuroscience 258:101-110.
50. Zheng T, Liu L, Shi J, Yu X, Xiao W, Sun R, Zhou Y, Aa J, Wang G. 2014. The metabolic impact of methamphetamine on the systemic metabolism of rats and potential markers of methamphetamine abuse. Mol Biosyst 10:1968-1977.
51. Zhu J, Chen Y, Zhao N, Cao G, Dang Y, Han W, Xu M, Chen T. 2012. Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens. J Neurosci Res 90:895-904.